It is difficult to look forward to 2024 without some degree of trepidation. After all, just because 2023 was exceptionally bad for most small caps, we are not necessarily due
5 downtrodden shares highlighted from Q4 2022, RENE, ANGS, GCAT, BIDS & ALL what to do next
ReNeuron, Angus Energy, Caracal Gold, Bidstack, and Atlantic Lithium have not performed as hoped. Where next?
Why UK small-cap biotech shares are going extinct, AVCT, RENE, POLX, HVO & HEMO
When a UK biotech firm starts to show promise, they set sail across the Atlantic. Investors can’t blame them.
RNS Hotlist with Zak Mir: ORCA, BOIL, TM1, FME, CRDL, ZPHR, CAU, SGZ & RENE via Vox Markets
Orcadian Energy (ORCA), the North Sea oil and gas development company, provided an update of its applications in the 33rd Offshore Licensing Round which closed last week.
RNS Hotlist with Zak Mir: GGP, GLR, BANK, RENE, BRSD, HZM, PANR, BMV, BVC, EISB, INSP, TERN, MAST & EVG via Vox Markets
Greatland Gold (GGP), the mining development and exploration company, provided an exploration and development update at the Havieron gold-copper project in the Paterson region of Western Australia.
Traders Cafe “Bank Holiday Edition” with Zak Mir: Bulletin Board Heroes, Sunday 4th September 2022 via Vox Markets
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Bitcoin, African Pioneer, Bango,
Traders Cafe with Zak Mir: Bulletin Board Heroes, Thursday 17th March 2022 via Vox Markets
Zak Mir takes a charting perspective on some of the most followed London small caps. Today’s selection includes Agronomics, Berkeley, Bowleven, Cap-X, DeepVerge, Eve, Osirium, Ovoca, Rambler, Reneuron, Rotala, Saietta,
Traders Cafe with Zak Mir: THG, ORPH, ORCP, BOOM, DEV, ASLR, HEMO, QTZ, THR, BHL, CRCL, DEFI, HGEN, RENE, DEST & CCZ
It may be that after today’s announcement that bears of THG (THG) feel that they may be on the wrong side of the price action. The company said CEO Matthew
Olav Hellebo, CEO of ReNeuron Group plc (RENE.L) Interview.
ReNeuron is a global leader in cell-based therapeutics, harnessing its unique stem cell technologies to develop ‘off the shelf’ stem cell treatments, without the need for immunosuppressive drugs. The Company’s
Best AIM stocks of 2019: Who’s up 1,700% so far?
As 2019 ends, we run through the best and worst AIM stocks this year and why small-caps are rallying.
Best AIM stocks of 2019: Who’s up 1,700% so far?
As 2019 ends, we run through the best and worst AIM stocks this year and why small-caps are rallying.
Share Talk Bulletin Board Heroes, Friday 30th August 2019
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update.